Two Doses of Multimeric-001 (M-001) Followed by Influenza Vaccine

Clinical trial NCT03058692 · COMPLETED

Trial details

NCT number: NCT03058692
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Influenza Influenza Immunisation

Start date: 2018-04-09
Primary completion: 2019-01-14
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.